CRESLECT, created in 2007 (United States), from 142 sister brands and 17477 competing brands. The CRESLECT brand is owned by Amgen, a company listed in New York. CRESLECT belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Amgen
(CRESLECT)
over 5 years*
USD 401.68